|
|
|
|
|
| Research progress on low triiodothyronine syndrome in critically ill patients |
| Li Li, Wu Cai-jun |
|
|
|
|
Abstract Low triiodothyronine syndrome is associated with T3 reducing non-thyroid disease. The main feature is the decline of T3 level. Thyroid stimulating hormone (TSH) is in the normal range. Clinically, there is no hypothyroidism, and most of the critically ill patients are accompanied by low triiodothyronine syndrome. This article reviews the pathogenesis, clinical significance and treatment progress of low triiodothyronine syndrome in critically ill patients.
|
|
|
|
Corresponding Authors:
Department of Emergency, Dongzhimen Hospital, Beijing University of Chinese Medicine, Institute of Sepsis, Beijing University of Traditional Chinese Medicine Beijing 100007, China
|
|
|
|
| ［1］Alevizaki M, Synetou M, Xynos K, et al. Low triiedathyronine:a strong predictor of outcome in acute stroke Patients［J］. Eur J Clin Invest, 2007, 37(8):651-657.
［2］Bermudez F， Surks MI， Oppenheimer JH.High incidence of decreased serum triiodothyronine concentration in patients with nonthyroidal disease［J］.J Clin Endocrinol Metab, 1975, 41(1):27-40.
［3］谢日升.危重患者血清甲状腺激素水平变化的临床意义［J］.现代中医， 2009, 9（5）：72-73.
［4］李轶,徐南平.危重症神经内分泌激素的变化［J］.实用临床医学， 2015, 16（4）:104-107.
［5］周晓莉，饶一武.应激状态下患者下丘脑-垂体-肾上腺轴功能的变化［J］.医学综述， 2014, 20（13）：2439-2440.
［6］孙秋岩，单忠艳，滕卫平,等.应激对下丘脑-垂体-甲状腺轴影响的研究进展［J］.山东医药， 2015, 55（17）：92-94.
［7］Williams GR, Franklyn JA,Neuberger JM, et al. Thyroid hormone receptor expression in the "sick euthyroid" sundrome［J］. Lancet, 1989, 2(8678-8679):1477-1481.
［8］龚江锋.内科危重病患者血清甲状腺激素水平的检测分析［J］.中国基层医药， 2012, 19（20）：3113-3114.
［9］白剑，郭晋平，吕广欣.危重症患者血清甲状腺激素水平变化及意义［J］.山东医药， 2016, 56（12）:83-85.
［10］Nagaya T, Fujioda M, Otsuka G, et al. A potential role of activated NF-κB in the pathogenesis of enthyroid sick syndrome［J］. J Clin Invest, 2000, 1006(3):393-402.
［11］王秀梅，宋丽洁，张金红.正常甲状腺病态综合征［J］.中国急救复苏与灾害医学杂志， 2013, 8（6）：564-566.
［12］韩晶，艾华.内脂素与甲状腺素关系的研究进展［J］.医学研究生学报， 2012, 25（9）：985-988.
［13］刘艳清，张珍，邵加庆.低T3综合征研究进展［J］.医学研究生学报， 2014, 27（9）：978-981.
［14］韩刚.外科病人的低T3综合症［J］.肠外与肠内营养， 2017, 24（5）：260-262，266.
［15］凌云，叶初阳，何松彬.ICU危重患者甲状腺激素水平监测及预后评估［J］.南方医科大学学报， 2008， 28（8）：1496-1497.
［16］杨赓，秦俭.125例老年危重症患者血清甲状腺激素变化的临床意义［J］.齐齐哈尔医学院学报， 2008， 29（14）：1681-1683.
［17］张慧敏，黄鹏，刘丽，等.老年危重症患者血清甲状腺激素水平的变化与预后的关系［J］.临床荟萃， 2011， 26（3）：212-214.
［18］马海英，申丽旻，赵鹤龄.甲状腺激素对危重症患者病情严重程度的评估［J］.中国综合临床， 2010， 26（9）：937-939.
［19］廖深福，胡媛，林爱华，等.动态监测ICU 非甲状腺疾病危重症患者甲状腺激素水平与患者预后的研究［J］.中外医疗， 2017， 36（4）：9-11.
［20］Gao R, Chen RZ, Xia Y， et al. Low T3 syndrome as a predictor of poor prognosis in chronic lymphocytic leukemia［J］. Int J Cancer， 2018， 143（3）：466-477.
［21］Bertoli A, Valentini A, Cianfarani MA, et al. Low FT3: a possible marker of frailty in the elderly［J］. Clin Interv Aging, 2017, 12: 335-341.
［22］Lee YM, Ki YJ, Choi DH, et al. Value of Low Triiodothyronine and subclinical myocardial injury for clinical outcomes in chest pain［J］. Am J Med Sci, 2015, 350 (5):393-397.
［23］Bello G, Pennisi MA, Montini L, et al. Nonthyroidal illness syndrome and prolonged mechanical ventilation in patients admitted to the ICU［J］. Chest, 2009, 135(6):1448-1454.
［24］Scoscia E， Baglioni S， Eslami A， et al. Low triiodothymnine(T3) state: a predictor of outcome in respiratory failure results of a clinical pilot study［J］． Eur J Endocrinol， 2004， 151(5)：557-560．
［25］Su W, Zhao XQ, Wang M, et al. Low T3 syndrome improves risk prediction of in-hospital cardiovascular death in patients with acute myocardial infarction［J］. J Cardiol, 2018, 72（3）：215-219.
［26］Bunevicius A, Deltuva VP, Tamasauskas S, et al. Preoperative low tri-iodothyronine concentration is associated with worse health status and shorter five year survival of primary brain tumor patients［J］. Oncotarget, 2017, 8(5):8648-8656.
［27］Lamba N, Liu C, Zaidi H, et al. A prognostic role for Low tri-iodothyronine syndrome in acute stroke patients: A systematic review and meta-analysis［J］. Clin Neurol Neurosurg, 2018, 169:55-63.
［28］Bunevicius A, Iervasi G, Bunevicius R. Neuroprotective actions of thyroid hormones and low-T3 syndrome as a biomarker in acute cerebrovascular disorders［J］. Expert Rev Neurother, 2015, 15 (3):315-326.
［29］Cerillo AG, Storti S, Kallushi E, et al. Thelowtriiodothyronine syndrome: a strong predictor of low cardiac output and death in patients undergoing coronary artery bypass grafting［J］. Ann Thorac Surg, 2014, 97(6):2089-2095.
［30］杨京平.正常甲状腺功能病态综合征认识现状［J］.中国全科医学， 2005， 8（12）：1026-1027.
［31］Kwakkel J, Wiersinga WM, Boelen A. Differential involvement of nuclear factor-kappaB and activator protein-1 pathways in the interleukin-1 beta-mediated decrease of deiodinase type 1 and thyroid hormone receptor betal mRNA［J］. J Endocrinol, 2006, 189(1):42-44.
［32］郑静，虞晓芳.危重病患者血清甲状腺激素水平检测分析［J］.中国基层医药， 2011， 18（8）：1134-1135.
［33］王晓勇.慢性阻塞性肺疾病合并低T3综合征32例临床分析［J］.大家健康， 2013， 7（2）：41.
［34］刘玥，龚玮琦，邵莉，等.老年心血管疾病住院患者低T3综合征临床研究［J］.医学临床研究， 2015， 32（4）：765-770.
［35］王长远，秦俭，王晶，等.老年危重症全身炎症反应综合征患者的甲状腺激素水平变化［J］.中国急救复苏与灾害医学杂志， 2007， 2（5）：264-268.
［36］方元,付蔷,严浩英.充血性心力衰竭患者血清甲状腺激素水平的变化及其临床意义［J］.华西医科大学学报， 1999, 30（2）：196-197.
［37］李春风，郭小刚，杨蕾，等.急性有机磷中毒患者血浆甲状腺激素水平的动态变化及意义［J］.中国急救医学, 2001， 21（10）：584-585.
［38］易海平.甲状腺素治疗老年充血性心力衰竭75例临床观察［J］.吉林医学， 2010， 31（15）：2210-2211.
［39］Amin A, Chitsazan M, Taghavi S, et al. Effects of triiodothyronine replacement therapy in patients with chronic stable heart failure and low-triiodothyronine syndrome: a randomized,double-blind, placebo-controlled study［J］. ESC Heart Fail, 2015， 2 (1):5-11.
［40］段敏虹,陈广原.非甲状腺疾病危重病人甲状腺功能异常综合征探讨［J］.广州医学院学报, 2006, 34(2):34-36.
［41］Stathatos N, Levetan C, Burman KD, et al. The controversy of the treatment of critically ill patients with thyroid hormonr［J］. Best Pract Res Clin Endocrinol Metab, 2001, 15(4）：465-478.
［42］Peeters RP, van der Geyten S, Wouters PJ, et al. Tissue thyroid hormone levels in critical illness［J］. J Clin Endocrinol Metab, 2005, 90(12):6498-6507.
［43］Pantos C, Mourouzis I, Cokkinos DV, et al. New insights into the role of thyroid hormone in cardiacremodeling:time to reconsider［J］. Heart Fail Rev, 2001, 16(1):79-96. |
|
|
|
Address: 1 North 2nd Street,
Zhongguancun, 
